Concepedia

Terrence Kenakin

TK

10

Publications

435

Citations

10

H-Index

1980

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

GlaxoSmithKline (United States)

Terrence Kenakin is an author at University of North Carolina at Chapel Hill specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

1980–2020

10

Publications

10

Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor

Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps et al. · ACS Chemical Neuroscience · 2017 · 106 citations

Discovery of the Potent and Selective M1 PAM-Agonist<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-Hydroxytetrahydro-2<i>H</i>-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects

Jennifer E. Davoren, Che‐Wah Lee, Michelle R. Garnsey et al. · Journal of Medicinal Chemistry · 2016 · 83 citations · Full text

Antagonism of an indirectly acting agonist: Block by propranolol and sotalol of the action of tyramien on rat heart

J.W. Black, Donald H. Jenkinson, Terrence Kenakin · European Journal of Pharmacology · 1980 · 43 citations

, , +5

Quantitative Molecular Pharmacology and Informatics in Drug Discovery

Michael W. Lutz, Terrence Kenakin · Medical Entomology and Zoology · 1999 · 39 citations

, , +13

Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT<sub>1</sub> and MT<sub>2</sub> receptors

Céline Legros, Clémence Dupré, Chantal Brasseur et al. · Pharmacology Research & Perspectives · 2019 · 33 citations · Full text

Rows per page

1–5 of 10